A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer.

CONCLUSION: Although initially tolerated and effective in terms of locoregional disease control, disappointing survival outcomes compared to historical controls raise uncertainty that the piloted approach merits further pursuit in ATC. PMID: 31595822 [PubMed - as supplied by publisher]
Source: Thyroid : official journal of the American Thyroid Association - Category: Endocrinology Tags: Thyroid Source Type: research